Sartorius Stedim Biotech SA Share Price Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
04-23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
04-22 | Sartorius Stedim: in the red with brokerage comments | CF |
Sales 2024 * | 2.94B 3.14B 252B | Sales 2025 * | 3.35B 3.58B 287B | Capitalization | 20.27B 21.67B 1,736B |
---|---|---|---|---|---|
Net income 2024 * | 343M 367M 29.37B | Net income 2025 * | 459M 491M 39.3B | EV / Sales 2024 * | 7.66 x |
Net Debt 2024 * | 2.27B 2.42B 194B | Net Debt 2025 * | 2.15B 2.3B 184B | EV / Sales 2025 * | 6.69 x |
P/E ratio 2024 * |
57.7
x | P/E ratio 2025 * |
41.7
x | Employees | - |
Yield 2024 * |
0.36% | Yield 2025 * |
0.53% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 25/03/19 |
Chairman | 59 | 28/06/07 | |
Chief Tech/Sci/R&D Officer | 59 | 28/04/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 28/06/07 |
Chairman | 59 | 28/06/07 | |
Susan Dexter
BRD | Director/Board Member | 67 | 06/04/15 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock